Literature DB >> 20555032

IGF-I activation of the AKT pathway is impaired in visceral but not subcutaneous preadipocytes from obese subjects.

Kelly Cleveland-Donovan1, Laura A Maile, William G Tsiaras, Tamara Tchkonia, James L Kirkland, Charlotte M Boney.   

Abstract

Obesity morbidity is associated with excess visceral adiposity, whereas sc adipose tissue is much less metabolically hazardous. Human abdominal sc preadipocytes have greater capacity for proliferation, differentiation, and survival than omental preadipocytes. IGF-I is a critical mediator of preadipocyte proliferation, differentiation, and survival through multiple signaling pathways. We investigated IGF-I action in primary cultures of human preadipocytes isolated from sc and omental adipose tissue of obese subjects. IGF-I-stimulated DNA synthesis was significantly lower in omental compared with sc preadipocytes. IGF-I phosphorylation of the IGF-I receptor and the ERK pathway was comparable in sc and omental cells. However, omental preadipocytes had decreased insulin receptor substrate (IRS)-1 protein associated with increased IRS-1-serine(636/639) phosphorylation and degradation. IGF-I-stimulated phosphorylation of AKT on serine(473) but not threonine(308) was decreased in omental cells, and activation of downstream targets, including S6Kinase, glycogen synthase kinase-3, and Forkhead box O1 was also impaired. CyclinD1 abundance was decreased in omental cells due to increased degradation. Over-expression of IRS-1 by lentivirus in omental preadipocytes increased IGF-I-stimulated AKT-serine(473) phosphorylation. The mammalian target of rapamycin (mTOR)-Rictor complex regulates phosphorylation of AKT-serine(473) in 3T3-L1 adipocytes, but knockdown of Rictor by lentivirus-delivered short hairpin RNA in sc preadipocytes did not affect AKT-serine(473) phosphorylation by IGF-I. These data reveal an intrinsic defect in IGF-I activation of the AKT pathway in omental preadipocytes from obese subjects that involves IRS-1 but probably not mTOR-Rictor complex. We conclude that impaired cell cycle regulation by AKT contributes to the distinct growth phenotype of preadipocytes in visceral fat of obese subjects.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20555032      PMCID: PMC2940538          DOI: 10.1210/en.2010-0043

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  71 in total

1.  Functional significance of type 1 insulin-like growth factor-mediated nuclear translocation of the insulin receptor substrate-1 and beta-catenin.

Authors:  Jia Chen; An Wu; Hongzhi Sun; Robert Drakas; Cecilia Garofalo; Sandra Cascio; Eva Surmacz; Renato Baserga
Journal:  J Biol Chem       Date:  2005-06-20       Impact factor: 5.157

2.  Synergistic induction of cyclin D1 in oligodendrocyte progenitor cells by IGF-I and FGF-2 requires differential stimulation of multiple signaling pathways.

Authors:  Terra J Frederick; Jungsoo Min; Stefanie C Altieri; Nina E Mitchell; Teresa L Wood
Journal:  Glia       Date:  2007-08-01       Impact factor: 7.452

3.  Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex.

Authors:  D D Sarbassov; David A Guertin; Siraj M Ali; David M Sabatini
Journal:  Science       Date:  2005-02-18       Impact factor: 47.728

4.  PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth.

Authors:  Tianyan Gao; Frank Furnari; Alexandra C Newton
Journal:  Mol Cell       Date:  2005-04-01       Impact factor: 17.970

5.  Phosphoinositide 3-kinase is required for human adipocyte differentiation in culture.

Authors:  D Aubin; A Gagnon; A Sorisky
Journal:  Int J Obes (Lond)       Date:  2005-08       Impact factor: 5.095

6.  Characterization of differentiated subcutaneous and visceral adipose tissue from children: the influences of TNF-alpha and IGF-I.

Authors:  Malcolm Grohmann; Matthew Sabin; Jeff Holly; Julian Shield; Elizabeth Crowne; Claire Stewart
Journal:  J Lipid Res       Date:  2004-10-16       Impact factor: 5.922

7.  Serine 332 phosphorylation of insulin receptor substrate-1 by glycogen synthase kinase-3 attenuates insulin signaling.

Authors:  Ziva Liberman; Hagit Eldar-Finkelman
Journal:  J Biol Chem       Date:  2004-11-30       Impact factor: 5.157

8.  Influence of obesity and insulin sensitivity on insulin signaling genes in human omental and subcutaneous adipose tissue.

Authors:  R MacLaren; W Cui; S Simard; K Cianflone
Journal:  J Lipid Res       Date:  2007-11-06       Impact factor: 5.922

9.  Abundance of two human preadipocyte subtypes with distinct capacities for replication, adipogenesis, and apoptosis varies among fat depots.

Authors:  Tamara Tchkonia; Yourka D Tchoukalova; Nino Giorgadze; Tamar Pirtskhalava; Iordanes Karagiannides; R Armour Forse; Ada Koo; Michael Stevenson; Dharmaraj Chinnappan; Andrew Cartwright; Michael D Jensen; James L Kirkland
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-09-21       Impact factor: 4.310

10.  Isoform-specific defects of insulin stimulation of Akt/protein kinase B (PKB) in skeletal muscle cells from type 2 diabetic patients.

Authors:  D Cozzone; S Fröjdö; E Disse; C Debard; M Laville; L Pirola; H Vidal
Journal:  Diabetologia       Date:  2008-01-18       Impact factor: 10.122

View more
  27 in total

1.  Role of substance P in the regulation of glucose metabolism via insulin signaling-associated pathways.

Authors:  Iordanes Karagiannides; Kyriaki Bakirtzi; Efi Kokkotou; Dimitris Stavrakis; Kara Gross Margolis; Thomas Thomou; Nino Giorgadze; James L Kirkland; Charalabos Pothoulakis
Journal:  Endocrinology       Date:  2011-10-18       Impact factor: 4.736

2.  Insulin-like growth factor-1 activates different catalytic subunits p110 of PI3K in a cell-type-dependent manner to induce lipogenesis-dependent epithelial-mesenchymal transition through the regulation of ADAM10 and ADAM17.

Authors:  Ga Bin Park; Daejin Kim
Journal:  Mol Cell Biochem       Date:  2017-08-17       Impact factor: 3.396

3.  IGFBP4 Is Required for Adipogenesis and Influences the Distribution of Adipose Depots.

Authors:  David E Maridas; Victoria E DeMambro; Phuong T Le; Subburaman Mohan; Clifford J Rosen
Journal:  Endocrinology       Date:  2017-10-01       Impact factor: 4.736

4.  Preferential impact of pregnancy-associated plasma protein-A deficiency on visceral fat in mice on high-fat diet.

Authors:  Cheryl A Conover; Sara L Harstad; Tamar Tchkonia; James L Kirkland
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-09-17       Impact factor: 4.310

Review 5.  Mechanisms and metabolic implications of regional differences among fat depots.

Authors:  Tamara Tchkonia; Thomas Thomou; Yi Zhu; Iordanes Karagiannides; Charalabos Pothoulakis; Michael D Jensen; James L Kirkland
Journal:  Cell Metab       Date:  2013-04-11       Impact factor: 27.287

Review 6.  Insulin signalling mechanisms for triacylglycerol storage.

Authors:  M P Czech; M Tencerova; D J Pedersen; M Aouadi
Journal:  Diabetologia       Date:  2013-02-27       Impact factor: 10.122

7.  Effects of Bariatric Surgery on Change of Brown Adipocyte Tissue and Energy Metabolism in Obese Mice.

Authors:  Yuanwen Chen; Jianjun Yang; Xin Nie; Zhicheng Song; Yan Gu
Journal:  Obes Surg       Date:  2018-03       Impact factor: 4.129

8.  Insulin-like growth factor I, growth hormone, and insulin sensitivity: the effects of a one-year cholecalciferol supplementation in middle-aged overweight and obese subjects.

Authors:  Elena Kamycheva; Vivian Berg; Rolf Jorde
Journal:  Endocrine       Date:  2012-10-30       Impact factor: 3.633

9.  Polymorphism analysis and expression patterns of the IGF1 gene in the Shitou goose.

Authors:  Jun Tang; Mao Guo; Jing Fu; Hongjia Ouyang; Yunbo Tian; Xu Shen; Yunmao Huang
Journal:  Arch Anim Breed       Date:  2021-07-22

10.  MALAT1 Regulated mTOR-Mediated Tau Hyperphosphorylation by Acting as a ceRNA of miR144 in Hippocampus Cells Exposed to High Glucose.

Authors:  Chong Lu; Yikui Zhao; Yan Cao; Li Liu; Shanshan Wu; Dongbin Li; Shuang Liu; Shuyuan Xiao; Yafen Wei; Xinyu Li
Journal:  Clin Interv Aging       Date:  2021-06-22       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.